Kuwano H - Search Results

1

Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.

Endoh H, Tomida S, Yatabe Y, Konishi H, Osada H, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Endoh H, et al. Among authors: kuwano h. J Clin Oncol. 2004 Mar 1;22(5):811-9. doi: 10.1200/JCO.2004.04.109. J Clin Oncol. 2004. PMID: 14990636

2

PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients.

Endoh H, Yatabe Y, Kosaka T, Kuwano H, Mitsudomi T. Endoh H, et al. Among authors: kuwano h. J Thorac Oncol. 2006 Sep;1(7):629-34. J Thorac Oncol. 2006. PMID: 17409929 Free article.

3

Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma.

Kosaka T, Yatabe Y, Onozato R, Kuwano H, Mitsudomi T. Kosaka T, et al. Among authors: kuwano h. J Thorac Oncol. 2009 Jan;4(1):22-9. doi: 10.1097/JTO.0b013e3181914111. J Thorac Oncol. 2009. PMID: 19096302 Free article. Clinical Trial.

4

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Kosaka T, et al. Among authors: kuwano h. Cancer Res. 2004 Dec 15;64(24):8919-23. doi: 10.1158/0008-5472.CAN-04-2818. Cancer Res. 2004. PMID: 15604253

5

Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib.

Kosaka T, Yatabe Y, Endoh H, Yoshida K, Hida T, Tsuboi M, Tada H, Kuwano H, Mitsudomi T. Kosaka T, et al. Among authors: kuwano h. Clin Cancer Res. 2006 Oct 1;12(19):5764-9. doi: 10.1158/1078-0432.CCR-06-0714. Clin Cancer Res. 2006. PMID: 17020982

6

LKB1 gene mutations in Japanese lung cancer patients.

Onozato R, Kosaka T, Achiwa H, Kuwano H, Takahashi T, Yatabe Y, Mitsudomi T. Onozato R, et al. Among authors: kuwano h. Cancer Sci. 2007 Nov;98(11):1747-51. doi: 10.1111/j.1349-7006.2007.00585.x. Epub 2007 Aug 16. Cancer Sci. 2007. PMID: 17711506 Free PMC article.

7

Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers.

Onozato R, Kosaka T, Kuwano H, Sekido Y, Yatabe Y, Mitsudomi T. Onozato R, et al. Among authors: kuwano h. J Thorac Oncol. 2009 Jan;4(1):5-11. doi: 10.1097/JTO.0b013e3181913e0e. J Thorac Oncol. 2009. PMID: 19096300 Free article.

8

Analysis of ERBB4 mutations and expression in japanese patients with lung cancer.

Tomizawa K, Suda K, Onozato R, Kuwano H, Yatabe Y, Mitsudomi T. Tomizawa K, et al. Among authors: kuwano h. J Thorac Oncol. 2010 Nov;5(11):1859-61. doi: 10.1097/JTO.0b013e3181f1c433. J Thorac Oncol. 2010. PMID: 20975381 Free article.

9

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers.

Tomizawa K, Suda K, Onozato R, Kosaka T, Endoh H, Sekido Y, Shigematsu H, Kuwano H, Yatabe Y, Mitsudomi T. Tomizawa K, et al. Among authors: kuwano h. Lung Cancer. 2011 Oct;74(1):139-44. doi: 10.1016/j.lungcan.2011.01.014. Epub 2011 Feb 25. Lung Cancer. 2011. PMID: 21353324

10

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

Endoh H, Yatabe Y, Shimizu S, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Endoh H, et al. Among authors: kuwano h. Int J Cancer. 2003 Aug 10;106(1):45-51. doi: 10.1002/ijc.11184. Int J Cancer. 2003. PMID: 12794755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,185 results

Search Page

Filters